250 related articles for article (PubMed ID: 28796038)
1. Clomiphene citrate is associated with favorable cycle characteristics but impaired outcomes of obese women with polycystic ovarian syndrome undergoing ovarian stimulation for in vitro fertilization.
Jiang S; Kuang Y
Medicine (Baltimore); 2017 Aug; 96(32):e7540. PubMed ID: 28796038
[TBL] [Abstract][Full Text] [Related]
2. Progestin-primed milder stimulation with clomiphene citrate yields fewer oocytes and suboptimal pregnancy outcomes compared with the standard progestin-primed ovarian stimulation in infertile women with polycystic ovarian syndrome.
Ye H; Tian H; He W; Lyu Q; Kuang Y; Chen Q; Sun L
Reprod Biol Endocrinol; 2018 May; 16(1):53. PubMed ID: 29807533
[TBL] [Abstract][Full Text] [Related]
3. Controlled Ovarian Stimulation Using Medroxyprogesterone Acetate and hMG in Patients With Polycystic Ovary Syndrome Treated for IVF: A Double-Blind Randomized Crossover Clinical Trial.
Wang Y; Chen Q; Wang N; Chen H; Lyu Q; Kuang Y
Medicine (Baltimore); 2016 Mar; 95(9):e2939. PubMed ID: 26945402
[TBL] [Abstract][Full Text] [Related]
4. The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments.
Zhu X; Ye H; Fu Y
Medicine (Baltimore); 2016 Jul; 95(28):e4193. PubMed ID: 27428219
[TBL] [Abstract][Full Text] [Related]
5. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization.
Kuang Y; Chen Q; Fu Y; Wang Y; Hong Q; Lyu Q; Ai A; Shoham Z
Fertil Steril; 2015 Jul; 104(1):62-70.e3. PubMed ID: 25956370
[TBL] [Abstract][Full Text] [Related]
6. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
[TBL] [Abstract][Full Text] [Related]
7. Progestin-Primed Ovarian Stimulation with Dydrogesterone versus Medroxyprogesterone Acetate in Women with Polycystic Ovarian Syndrome for in vitro Fertilization: A Retrospective Cohort Study.
Huang J; Xie Q; Lin J; Lu X; Zhu J; Gao H; Cai R; Kuang Y
Drug Des Devel Ther; 2019; 13():4461-4470. PubMed ID: 32099323
[TBL] [Abstract][Full Text] [Related]
8. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
Jiang S; Kuang Y
Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
[TBL] [Abstract][Full Text] [Related]
9. Gonadotrophins for ovulation induction in women with polycystic ovary syndrome.
Weiss NS; Kostova E; Nahuis M; Mol BWJ; van der Veen F; van Wely M
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD010290. PubMed ID: 30648738
[TBL] [Abstract][Full Text] [Related]
10. The pregnancy outcome of progestin-primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing in vitro fertilisation: a randomised controlled trial.
Dong J; Wang Y; Chai WR; Hong QQ; Wang NL; Sun LH; Long H; Wang L; Tian H; Lyu QF; Lu XF; Chen QJ; Kuang YP
BJOG; 2017 Jun; 124(7):1048-1055. PubMed ID: 28276192
[TBL] [Abstract][Full Text] [Related]
11. Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression.
Branigan EF; Estes MA
Fertil Steril; 2000 Mar; 73(3):587-90. PubMed ID: 10689017
[TBL] [Abstract][Full Text] [Related]
12. Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist.
Lu X; Hong Q; Sun L; Chen Q; Fu Y; Ai A; Lyu Q; Kuang Y
Fertil Steril; 2016 Nov; 106(6):1356-1362. PubMed ID: 27490046
[TBL] [Abstract][Full Text] [Related]
13. Thorough sonographic oocyte retrieval during in vitro fertilization produces results similar to ovarian wedge resection in patients with clomiphene citrate-resistant polycystic ovarian syndrome.
Branigan EF; Estes A; Walker K; Rothgeb J
Am J Obstet Gynecol; 2006 Jun; 194(6):1696-700; discussion 1700-1. PubMed ID: 16731088
[TBL] [Abstract][Full Text] [Related]
14. [Optimal Ovulation Induction in Polycystic Ovary Syndrome Resistant to Clomiphene Citrate or Letrozole.].
Chen Y; Zhang D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):874-877. PubMed ID: 28598116
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of assistant treatment proposals for infertile women with polycystic ovary syndrome].
Chen ZJ; Shi YH; Li Y; Gao Q; Sheng Y; Ma ZX
Zhonghua Fu Chan Ke Za Zhi; 2008 Aug; 43(8):571-5. PubMed ID: 19087489
[TBL] [Abstract][Full Text] [Related]
16. Progestin-Primed Ovarian Stimulation Versus Mild Stimulation Protocol in Advanced Age Women With Diminished Ovarian Reserve Undergoing Their First
Tu X; You B; Jing M; Lin C; Zhang R
Front Endocrinol (Lausanne); 2021; 12():801026. PubMed ID: 35140685
[TBL] [Abstract][Full Text] [Related]
17. Utrogestan as an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization.
Zhu X; Zhang X; Fu Y
Medicine (Baltimore); 2015 May; 94(21):e909. PubMed ID: 26020402
[TBL] [Abstract][Full Text] [Related]
18. Progestin-primed ovarian stimulation with or without clomiphene citrate supplementation in normal ovulatory women undergoing in vitro fertilization/intracytoplasmic sperm injection: A prospective randomized controlled trial.
Liu Y; Chen Q; Yu S; Wang Y; He W; Chang HY; Wang B; Gao H; Long H; Wang L; Lyu Q; Ai A; Kuang Y
Clin Endocrinol (Oxf); 2018 Mar; 88(3):442-452. PubMed ID: 29247457
[TBL] [Abstract][Full Text] [Related]
19. Use of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study.
Xi W; Liu S; Mao H; Yang Y; Xue X; Lu X
Drug Des Devel Ther; 2015; 9():6001-8. PubMed ID: 26648691
[TBL] [Abstract][Full Text] [Related]
20. Elevated basal luteinizing hormone does not impair the outcome of human menopausal gonadotropin and medroxyprogesterone acetate treatment cycles.
Sun L; Ye J; Wang Y; Chen Q; Cai R; Fu Y; Tian H; Lyu Q; Lu X; Kuang Y
Sci Rep; 2018 Sep; 8(1):13835. PubMed ID: 30217999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
